We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Rubicon Genomics Raises $2M

Read time: Less than a minute
BroadOak Capital Partners led the round, joined by Research Corporation Technologies.

The Ann Arbor, Michigan-based sample prep firm said it will use the proceeds to develop new and existing products, including its ThruPlex Plasma-seq liquid biopsy kit, and to add to its sales and marketing. Among the firm's other products are the ThruPLEX DNA-seq, PicoPLEX DNA-seq, and PicoPLEX WGA Kits.

"This investment reflects our view that Rubicon is an important player in one of the fastest growing markets in life sciences–next-generation sequencing," BroadOak Managing Partner Bill Snider said in a statement.